🇺🇸 FDA
Patent

US 8729100

Method and composition for treating an alpha adrenoceptor-mediated condition

granted A61KA61K31/145A61K31/445

Quick answer

US patent 8729100 (Method and composition for treating an alpha adrenoceptor-mediated condition) held by VANDA PHARMACEUTICALS INC. expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/145, A61K31/445, A61K31/454, A61K31/473